Nifty can target 16,650 in the short-term, says Vinay Rajani

The technical analyst from HDFC Securities also recommends buying CCL Products and Torrent Pharma.

null
Vinay Rajani Mumbai
2 min read Last Updated : Jul 13 2022 | 7:40 AM IST

Nifty View

The Nifty has been forming higher tops and higher bottoms on the daily charts, which indicates short term uptrend. The previous swing high is placed at 15,927, which can act as reversal point in the current running correction on the Nifty. 

Historically, the month of July is the second best performing month after December, if we were to go by the trend seen in last 29 years of benchmark Index.

The strategy for the coming sessions should be to accumulate longs on dips. The Nifty should be held long with a stop loss at 15,800. On the upside, the Nifty could target 16,650 in the short-term.

CCL Products
BUY

Buy Range: Rs 402.50 - Rs 390
Targets: Rs 440, Rs 460
Stop Loss: Rs 380

The stock has broken out from the downward sloping trend line on the daily line chart. The price breakout is accompanied with rising volumes.

The stock price has recently surpassed its 50- and 200-day EMA resistance. The stock price has also broken out from “Pennant” pattern on the daily chart. Higher top and higher bottom 
formation on the daily chart.

Indicators and oscillators have turned bullish on the daily and weekly chart. The stock can be bought in two tranches one at CMP and second at Rs 390, for targets of Rs 440 and Rs 460, keeping a Stop Loss at Rs 380.

Torrent Pharma
BUY

Buy Range: Rs 1,483 - Rs 1,435
Targets: Rs 1,560, Rs 1,600
Stop Loss: Rs 1,420

The stock price has surpassed the previous swing high resistance and is currently trading above its 20, 50 and 200 DMAs.

The pimary trend of the stock is bullish with higher tops and higher bottoms on weekly charts. Further, +DI has crossed -DI on the upside on daily charts, which indicates short term trend reversal.

The daily RSI has been rising and has reached above benchmark level of 50. The stock can be bought in two tranches one at CMP and second at Rs 1,435, for targets of Rs 1,560 and Rs 1,600, keeping a Stop Loss at Rs 1,420.

(Vinay Rajani, Senior Technical and Derivative Research Analyst at HDFC securities. Views expressed are personal).

 

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Nifty OutlookMarket trendsCCL ProductsTorrent PharmaStocks to buytechnical chartsstocks technical analysis

First Published: Jul 13 2022 | 7:38 AM IST

Next Story